These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 11266801

  • 1. CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis.
    Li W, Lu L, Wang Z, Wang L, Thomson A, Fung J, Qian S.
    Transplant Proc; 2001; 33(1-2):246-7. PubMed ID: 11266801
    [No Abstract] [Full Text] [Related]

  • 2. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
    Fu F, Li W, Lu L, Fung JJ, Thomson AW, Qian S.
    Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185
    [No Abstract] [Full Text] [Related]

  • 3. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
    Fu F, Li W, Lu L, Thomson AW, Fung JJ, Qian S.
    Transplant Proc; 1999; 31(1-2):1244. PubMed ID: 10083555
    [No Abstract] [Full Text] [Related]

  • 4. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, Gajewski T, Bluestone J.
    Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of corneal allograft reaction by CTLA4-Ig.
    Hoffmann F, Zhang EP, Pohl T, Kunzendorf U, Wachtlin J, Bulfone-Paus S.
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
    [Abstract] [Full Text] [Related]

  • 6. Protection of corneal allografts by CTLA4-Ig.
    Gebhardt BM, Hodkin M, Varnell ED, Kaufman HE.
    Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.
    Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, Uchida K, Hamada H, Takagi H.
    Transplant Proc; 1997 May; 29(3):1738-9. PubMed ID: 9142255
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA, Peng L, Liang X, Chen Z, Wang L, Ma L, Hackstein H, Robbins PD, Thomson AW, Fung JJ, Qian S, Lu L.
    J Immunol; 2002 Sep 15; 169(6):3382-91. PubMed ID: 12218160
    [Abstract] [Full Text] [Related]

  • 12. Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40.
    Steurer W, Oellinger R, Perwanger F, Brandacher G, Obrist P, Klima G, Margreiter R.
    Transplant Proc; 2001 Sep 15; 33(1-2):274-5. PubMed ID: 11266816
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses.
    Li W, Lu L, Wang L, Wang Z, Thomson AW, Fung JJ, Qian S.
    Transplant Proc; 2001 Sep 15; 33(1-2):525. PubMed ID: 11266939
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
    Kurlberg G, Haglind E, Schön K, Törnqvist H, Lycke N.
    Scand J Immunol; 2000 Mar 15; 51(3):224-30. PubMed ID: 10736090
    [Abstract] [Full Text] [Related]

  • 17. Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig.
    Zhou P, Szot G, Guo Z, Kim O, He G, Wang J, Grusby M, Newell K, Thistlethwaite J, Bluestone J, Alegre M.
    Transplant Proc; 2001 Mar 15; 33(1-2):214-6. PubMed ID: 11266784
    [No Abstract] [Full Text] [Related]

  • 18. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML.
    J Exp Med; 1998 Jul 06; 188(1):199-204. PubMed ID: 9653096
    [Abstract] [Full Text] [Related]

  • 19. Role of CTLA 4-Ig on induction of unresponsiveness to multiple minor alloantigens.
    Gorczynski RM, Kiziroglu F.
    Transpl Int; 1994 Jul 06; 7 Suppl 1():S599-601. PubMed ID: 11271318
    [Abstract] [Full Text] [Related]

  • 20. CTLA4-Ig treatment prolongs rat orthotopic liver graft survival.
    Tu Y, Rehman A, Flye MW.
    Transplant Proc; 1997 Jul 06; 29(1-2):1036-7. PubMed ID: 9123186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.